Tag Archives: Dementia Research

Dementia Moonshot Report: Research Priorities and Costs (Alzheimer’s Research UK)

Posted on January 25, 2020 by Dementia and Elderly Care News

Summary Alzheimer’s Research UK (ARUK) have released a brief report on six research priorities, which are: Achieving earlier detection of diseases which may cause dementia, (ideally by 10-15 years), to enhance development of new treatments / interventions for people most … Continue reading →

Posted in Alzheimer’s Research UK, Charitable Bodies, Commissioning, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Models of Dementia Care, National, Non-Pharmacological Treatments, Pharmacological Treatments, Quick Insights, UK, Universal Interest | Tagged Accelerating Alzheimer's Research and Drug Development, Accelerating Detection of Disease, Accelerating Detection of Disease (ADD) Challenge, Accelerating Detection of Disease Programme, Alzheimer's and Dementia: Translational Research and Clinical Interventions (TRCI), Alzheimer’s Research UK (ARUK), Alzheimer’s Research UK’s Dementia Attitudes Monitor, Alzheimer’s Research UK’s Drug Discovery Alliance, Awareness, Awareness Raising, Benefits of Detection and Early Intervention, Benefits of Early Detection, Biomarker Development, Biomarkers, Brain Health Clinics, Charity Research Support Fund, Cognitive Function and Ageing Study II, Cross-Funder Review, Dementia Access Taskforce, Dementia Consortium, Dementia Moonshot, Dementia Prevalence, Dementia Prevention, Dementia Research, Dementia Research and Drug Development, Dementia Research Funding, Dementia Research Priorities, Dementia Risk Reduction, Dementia Risk Reduction and Prevention, Dementia Translational Medicines Accelerator, Dementia: Prevalence and Detection, Dementias Platform UK, DPUK: Dementias Platform UK, Dr Helen Beaumont: Alzheimer’s Research UK Champion, Drug Development for Alzheimer's Disease, Drug Discovery Alliance, Drug Discovery Institutes, Drug Target Validation, Early Detection of Neurodegenerative Diseases, Economic Impact of Dementia, Global Impact of Dementia, Global Leadership, Government Research Funding, Grand Challenge on Artificial Intelligence and Data, Helen Stokes-Lampard: Chair of RCGP, Hilary Evans: Chief Executive of Alzheimer’s Research UK, Impact of Dementia, Impact of Dementia (Statistics), Impact of Dementia in UK, Life Sciences Industrial Strategy, Life-Changing Treatment for Dementia by 2025 (Moonshot Aim), Medical Research Charities, Mike Gooley Trailfinders Charity Prevention and Risk Reduction Fund, Modifiable Risk Factors, Multi-Morbidities, Multi-Morbidity, No Time to Lose: An Action Plan for Dementia (ARUK), Participation in Research, Patient Involvement in Research, Potential Drug Targets, Preclinical Biomarkers and Dementia, Preclinical Biomarkers in Alzheimer's Disease, Professor Jamie Waterall: National Lead for Cardiovascular Disease at Public Health England, Professor Tara Spires-Jones: Alzheimer’s Research UK Grant Review Board, Research Funding, Research Priorities and Funding / Costs, Research Priorities and Networks, Social and Economic Impact of Dementia, Social and Economic Impact of Dementia in UK, Target Robustness Programme, Translational Medicines, Translational Research, UK Dementia Research Institute, UK Dementia Research Institute (UK DRI), UK Health Research Funding | Leave a comment

More on the The Lancet Commission on Dementia Prevention, Intervention, and Care (Irish Journal of Psychological Medicine / Lancet)

Posted on September 29, 2019 by Dementia and Elderly Care News

Summary The Lancet Commission on Dementia Prevention, Intervention, and Care has produced recommendations for the prevention of dementia, proposing a “life-course model of dementia prevention” incorporating nine modifiable risk factors for reducing the risk of dementia. The commission also offers recommendations about the pharmacological, … Continue reading →

Posted in Alzheimer's Society, Alzheimer’s Research UK, Charitable Bodies, Commissioning, Community Care, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Integrated Care, Management of Condition, National, Non-Pharmacological Treatments, Person-Centred Care, Pharmacological Treatments, Quick Insights, UK, Universal Interest | Tagged Ageing Population, Ageing Population Carer Support, Alzheimer's Research UK, Australia, Barriers to Support, Behavioural Risk Factors, Behavioural Risk Factors and Dementia, Blood Pressure, Brighton and Sussex Medical School: University of Sussex, Cambridge Institute of Public Health: University of Cambridge, Camden and Islington NHS Foundation Trust, Canada, Center for Innovative Care in Aging: Johns Hopkins University, Centre for Clinical Brain Sciences: University of Edinburgh, Centre for Dementia Studies: Brighton and Sussex Medical School, Centre for Dementia Studies: University of Manchester, Centre for Dementia Studies: University of Sussex, Centre for Old Age Psychiatric Research (Innlandet Hospital Trust), Centre for Research in Ageing and Cognitive Health: University of Exeter, Centre for the Health Care of Elderly People: Dalhousie University, Cognitive Decline and Dementia: Risk Reduction, Cumulative Benefit of Reducing Risk Factors, Dalhousie University (Halifax; Canada), Delivery of Improved Practice by Increasing Knowledge and Informing Changes in Practice and Culture, Dementia and Sensory Loss, Dementia Policy, Dementia Prevention, Dementia Research, Dementia Research Centre: University College London, Dementia Research Priorities, Dementia Risk Factors, Dementia Risk Prevention, Dementia Risk Reduction, Dementia Risk Reduction and Prevention, Department of Health Promotion: Tel-Aviv University, Department of Medicine: University of Washington, Department of Neurology and Department of Psychiatry and the Behavioural Sciences: Keck School of Medicine, Department of Psychiatry and Behavioral Sciences: Johns Hopkins Bayview, Department of Psychiatry: University of Michigan, Department Psychosocial and Community Health: University of Washington, Diet and Dementia, Dietary Factors, Division of Psychiatry: University College London, Economic and Social Research Council (ESRC), Faculty of Medicine: University of Oslo, France, Geriatric Medicine: Dalhousie University, Healthy Ageing, Healthy and Active Ageing: Life-Course Approach (WHO), Healthy Lifestyles, Healthy Lifestyles and Public Health Programmes, Healthy Living, Heczeg Institute on Aging: Tel Aviv University, Increasing Knowledge of Risk and Protective Factors, Innlandet Hospital Trust (Norway), Inserm: Unit 1061, Institute of Health and Society: University of Oslo, Institute of Neurology: National Hospital for Neurology and Neurosurgery, Irish Journal of Psychological Medicine, Israel, Johns Hopkins University (Baltimore), Kaiser Permanente Washington Health Research Institute, Keck School of Medicine, La Colombière Hospital, Lancet, Lancet Commission on Dementia Prevention Intervention and Care, Lancet Commission on Dementia Prevention Intervention and Care (LCDPIC), Later Life, LCDPIC: Lancet Commission on Dementia Prevention Intervention and Care, Leonard Davis School of Gerontology: University of Southern California, Life-Course Approach to Healthy and Active Ageing, Life-Course Model of Dementia Prevention, Lifestyle Factors, Lifestyle Risk Factors, Lifestyle Weight Management, Loneliness, Loneliness and Social Isolation, Loneliness Harms Health, Marie Curie Palliative Care Research Department: University College London, Maximising Benefits to People Living With Dementia and Their Families of Seeking and Receiving a Diagnosis of Dementia, MCI: Mild Cognitive Impairment, Medical School: University of Exeter, Mediterranean Diet, Midlife Hypertension, Mild Cognitive Impairment (MCI), Minerva Center for Interdisciplinary Study of End of Life: Tel Aviv University, Modifiable Risk Factors, Mortality Risk Factors, National Ageing Research Institute (Australia) Academic Unit for Psychiatry of Old Age: University of Melbourne, Neurological Disorders, Neuroprotective Lifestyles, Neuropsychiatric Symptoms, Neuropsychiatric Symptoms in People With Dementia, Neuropsychiatric Symptoms of Alzheimer’s Disease, Neuropsychiatry - Epidemiological and Clinical Research: La Colombière Hospital, Norway, Norwegian National Advisory Unit on Aging and Health (Norway), Obesity, Obesity Risk Factor, Overlapping Risk Factors, Physical Activity and Health Benefits, Physical Activity Before Dementia, Physical Exercise, Physical Exercise Programmes, Physical Inactivity, Potentially Modifiable Socio-Environmental Risk Factors for Dementia, Preclinical Dementia and Associated Lifestyle Changes, Prevention, Prevention Agenda, Prevention Agenda Linking Dementia and Other Non-Communicable Diseases, Prevention Approaches, Prevention Better Than Cure, Prevention of Dementia, Prevention of Future Dementia Cases by Increasing Knowledge of Risk and Protective Factors, Prevention Programmes, Preventive Care, Psychosocial and Lifestyle-Related Risk Factors, Psychosocial Protective and Risk Factors, Public Health, Public Health Interventions, Quality of Life for People Affected by Dementia by Preventing and Treating Negative Consequences of Dementia, Quality of Life for People Affected by Dementia by Promoting Functional Capabilities and Independence, Reducing the Incidence of Dementia, Research Networks, Resources for Enhancing Alzheimer’s Caregiver Health intervention (REACH), Risk and Protective Factors, Risk Factors, Risk Factors and Preventive Interventions for Cognitive Impairment, Risk Factors and Preventive Interventions for Dementia, Risk Reduction of Cognitive Decline and Dementia, Sackler Faculty of Medicine: Tel-Aviv University, School of Nursing: University of Washington, School of Public Health: Tel Aviv University, Sedentary Lifestyles, Sensory Impairments, Smoking Cessation, Social Activities, Social Epidemiology, Social Isolation, Socioeconomically Disadvantaged Populations (NIA Health Disparities Populations), Staying Healthy for Longer, STrAtegies for RelaTives (START), Successful Ageing, Supporting Healthy Lifestyles, Supporting People Affected by Dementia, T2DM, Tel Aviv University, Tobacco, Tobacco Cessation, Tobacco Consumption, Type 2 Diabetes, Type 2 Diabetes Mellitus (T2DM), Type 2 Diabetes: Prevention, Unhealthy Behaviours, Unhealthy Lifestyles, Unhealthy Living, United States, University College London, University of Edinburgh, University of Exeter, University of Manchester, University of Melbourne, University of Michigan, University of Montpellier, University of Oslo, University of Southern California, University of Sussex, University of Washington, University of Washington (Seattle), USA, VA Center for Clinical Management Research (Ann Arbor USA), Vestfold Health Trust (Norway), Weight Management | Leave a comment

Blood Test Able to Predict Alzheimer’s Disease Decades Before Symptoms? (BBC News / Neurology)

Posted on August 3, 2019 by Dementia and Elderly Care News

Summary Research published in the Neurology journal claims a significant breakthrough in the development of a blood test (for plasma Aβ42/Aβ40) which may be able to predict Alzheimer’s Disease onset with 94% accuracy. Due caution: “But it’s important to note … Continue reading →

Posted in BBC News, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Quick Insights, Universal Interest | Tagged Alzheimer's Disease: Diagnosis, Alzheimer’s Early Screening, Amyloid, Amyloid and Tau PET, Amyloid Beta, Amyloid Beta (Aβ42 and Aβ40), Amyloid Beta Protein, Amyloid-β (Aβ), Amyloid-β Protein, BBC Health News, Biomarkers, Biomarkers Predicting Cognitive Decline and Alzheimer's Disease, Blood Proteins as Biomarkers of Disease Research, Blood Test for Brain Amyloidosis: Validated Using Amyloid PET and CSF p-tau181/Aβ42 as Reference Standards, Blood Tests, Blood-Based Biomarkers, Blood-Based Biomarkers of Pre-Symptomatic Alzheimer’s Disease, Brain Imaging, Brain Research, Case Finding, Conversion to Dementia From Prodromal Disease, Dementia Diagnosis, Dementia Innovation, Dementia Research, Dementia Screening, Department of Neurology: Washington University, Diagnosis, Diagnosis of Alzheimer's Disease, Diagnostic Imaging, Division of Biostatistics: Washington University, Drug Development for Alzheimer's Disease, Early Detection of Preclinical Disease, Early Diagnosis, Early Diagnosis of Alzheimer's Disease, Hope Center for Neurological Disorders: Washington University, Knight Alzheimer's Disease Research Center: Washington University, Mallinckrodt Institute of Radiology: Washington University, Neurology (Journal), Non-Invasive Biomarkers, Plasma Biomarkers, Plasma β-Amyloid 42/40, Plasma Protein Markers of MRI Measures in Asymptomatic Individuals, Preclinical Alzheimer's Disease, Preclinical Biomarkers in Alzheimer's Disease, Predictive Ability (of Tests), Prodromal Alzheimer's Disease, Protein-Based Biomarkers in Blood May Deliver Accurate Diagnoses, Rapid Screening, Recruitment Onto Dementia Clinical Trials, SAP (Protein), SAP: Serum Amyloid Protein, Screening, Screening for Dementia, Washington University School of Medicine | Leave a comment

The State of Dementia Research Globally: World Alzheimer Report 2018 (Alzheimer’s Disease International)

Posted on March 2, 2019 by Dementia and Elderly Care News

Summary The World Alzheimer Report 2018, entitled “The state of the art of dementia research: New frontiers”, reviews developments in dementia research, without glossing-over the absence of significant disease-modifying pharmacological treatment breakthroughs for around 20 years. This report examines wide-ranging … Continue reading →

Posted in Acute Hospitals, Alzheimer’s Disease International (ADI), Charitable Bodies, Community Care, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Management of Condition, Mental Health, Models of Dementia Care, Person-Centred Care, Quick Insights, Standards, Statistics, UK, Universal Interest | Tagged ADI’s World Alzheimer Reports, Alireza Atri: Director of Banner Sun Health Research Institute, Alzheimer's Research, Alzheimer’s Disease International (ADI), Alzheimer’s Disease Research Unit: McGill Centre for Studies in Ageing (Canada), Alzheimer’s Prevention Initiative: Banner Health (USA), Alzheimer’s Prevention Initiative: Banner Sun Health Research Institute, Banner Sun Health Research Institute, Burden of Alzheimer’s Disease, Burden of Dementia (Statistics), Centre for Dementia Prevention: University of Edinburgh, Dementia as Cause of Death, Dementia Awareness, Dementia Awareness Raising, Dementia Collaborative Research Centre: University of New South Wales, Dementia Discovery Fund, Dementia Discovery Fund (DDF), Dementia Prevention, Dementia Research, Dementia Research Funding, Dementia Research Priorities, Dementia Risk Reduction, Dementia Risk Reduction and Prevention, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies for Dementia, Disease-Modifying Treatments for Dementia, Dr Christopher Chen: Director of Memory Ageing and Cognition Centre at National University Health System: Singapore, Dr Doug Brown: Chief Executive Officer of British Society for Immunology, Dr Doug Brown: Former Chief Policy and Research Officer at Alzheimer’s Society, Dr Jennifer Bute: Dementia Alliance International (DAI), Dr Kenji Toba: President of National Centre for Geriatrics and Gerontology (Obu), Dr Maria Carrillo: Chief Science Officer at Alzheimer’s Association US, Dr Miia Kivipelto: Karolinska Institute, Dr Miia Kivipelto: Karolinska University Hospital (Stockholm), Dr Rachelle Doody: Global Head of Neurodegeneration at Roche, Dr Serge Gauthier: Director of Alzheimer’s Disease Research Unit at McGill Centre for Studies in Ageing in Canada, Drug Trials Failure Rate, Epidemiology, Epidemiology and Statistics, Francesca Colombo: Organisation for Economic Co-operation and Development (OECD), Fundación para la Lucha contra las Enfermedades Neurológicas (FLENI), Glenn Rees: Chairman of Alzheimer’s Disease International, Glenn Rees: Former CEO of Alzheimer’s Australia, Global Burden of Dementia, Global Dementia Discovery Fund (2015), Identification and Intervention for Dementia in Elderly Africans (IDEA Group), Jeff Cummings: Director of Cleveland Clinic at Lou Ruvo Centre for Brain Health, Kate Bingham: SV Health Managers, King’s College London, Market Failure (Dementia Research and Drug Development), Martin Knapp: London School of Economics, Memory Ageing and Cognition Centre at National University Health System: Singapore, Memory Ageing and Cognition Centre: National University Health System (Singapore), National Centre for Geriatrics and Gerontology (Japan), Optima (University of Oxford’s Dementia Research Project), OPTIMA Cohort (Oxford Project to Investigate Memory and Ageing), Oxford Project to Investigate Memory and Ageing (OPTIMA Study), Paola Barbarino: Alzheimer’s Disease International, Prevention, Prevention Agenda, Prevention of Future Dementia Cases by Increasing Knowledge of Risk and Protective Factors, Professor Adesola Ogunniyi: University College Hospital (Ibadan), Professor Bart De Strooper: Director of the UK Dementia Research Institute (UK DRI), Professor Craig Ritchie: Chair of Psychiatry of Ageing at University of Edinburgh, Professor Craig Ritchie: Director at Centre for Dementia Prevention, Professor Gordon Wilcock: Co-founder of Alzheimer’s Society UK, Professor Gordon Wilcock: Emeritus Professor of Geratology at University of Oxford, Professor Henry Brodaty: Director of Dementia Collaborative Research Centre at University of New South Wales, Professor Martin Knapp: Director of the Personal Social Services Research Unit at the London School of Economics and Political Science (LSE), Professor Martin Prince: Assistant Principal for Global Health at King’s College London, Research Networks, Ricardo Allegri: Head of Cognitive Neurology Neuropsychology and Neuropsychiatry at Fundación para la Lucha contra las Enfermedades Neurológicas (FLENI), Risk and Protective Factors, State of the Art of Dementia Research: New Frontiers (World Alzheimer Report 2018), Supporting People Affected by Dementia, UK Dementia Research Institute, UK Dementia Research Institute (UK DRI), UK Dementia Research Institute at UCL, University College Hospital (Ibadan Nigeria), World Alzheimer Report, World Alzheimer Report 2018: State of the Art of Dementia Research, World Alzheimer Report: 2018, World Alzheimer’s Day 2018 | Leave a comment

Roadmap for Dementia Research (International Journal of Geriatric Psychiatry / Alzheimer’s Society)

Posted on February 26, 2019 by Dementia and Elderly Care News

Summary Moving beyond the concentration upon research devoted to the discovery of pharmacological interventions for the treatment of dementia / Alzheimer’s Disease, the authors instead worked on a roadmap of complementary (non-pharmacological) research ambitions in the areas of prevention, diagnosis, … Continue reading →

Posted in Alzheimer's Society, Charitable Bodies, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, Management of Condition, Mental Health, Models of Dementia Care, National, Non-Pharmacological Treatments, Person-Centred Care, Personalisation, Quick Insights, UK, Universal Interest, Wales | Tagged Ageing Population, Ageing Population Carer Support, Alzheimer's Research UK, Alzheimer's Society, Alzheimer’s Society Research Network, Bangor University, Barriers to Support, Brighton and Sussex Medical School: University of Sussex, Cambridge Institute of Public Health: University of Cambridge, Centre for Dementia Studies: Brighton and Sussex Medical School, Centre for Research in Ageing and Cognitive Health: University of Exeter, Delivery of Improved Practice by Increasing Knowledge and Informing Changes in Practice and Culture, Dementia 2020 Challenge: 2018 Review Phase 1 (DHSC), Dementia Research, Dementia Research Priorities, Dementia Research Proposals, Dementia Services Development Centre: Bangor University, Division of Psychiatry: University College London, Enabling Dementia Workforce to Deliver Improved Practice by Increasing Knowledge and Informing Changes in Practice and Culture, Increasing Knowledge of Risk and Protective Factors, Institute for Ageing: Newcastle University, Institute for Health and Society: Newcastle University, International Journal of Geriatric Psychiatry, Katherine Cowan Consulting Ltd, Kings College London, London School of Economics and Political Science, LSE's Personal Social Services Research Unit (PSSRU), Maximising Benefits to People Living With Dementia and Their Families of Seeking and Receiving a Diagnosis of Dementia, National Dementia Strategies (UK), Newcastle University, Optimising Quality and Inclusivity of Health and Social Care Systems to Support People Affected by Dementia, Personal Social Service Research Unit (PSSRU), Personal Social Services Research Unit (PSSRU): London School of Economics and Political Science, Prevention of Future Dementia Cases by Increasing Knowledge of Risk and Protective Factors, PSSRU at LSE, PSSRU: London School of Economics and Political Science, Quality of Life for People Affected by Dementia by Preventing and Treating Negative Consequences of Dementia, Quality of Life for People Affected by Dementia by Promoting Functional Capabilities and Independence, Research Networks, Risk and Protective Factors, Roadmap to Advance Dementia Research by 2025 (Alzheimer’s Society), Roadmap to Advance Dementia Research by 2025: Care, Roadmap to Advance Dementia Research by 2025: Diagnosis, Roadmap to Advance Dementia Research by 2025: Interventions, Roadmap to Advance Dementia Research by 2025: Prevention, School of Clinical Medicine: University of Cambridge, Social Care Workforce Research Unit: King’s College London, Supporting People Affected by Dementia, University College London, University of Cambridge, University of Exeter, University of Exeter Medical School: University of Exeter, University of Sussex | Leave a comment

Plans for Meeting the Dementia Challenge by 2020 (DHSC)

Posted on February 24, 2019 by Dementia and Elderly Care News

Summary The Prime Minister’s Challenge on Dementia 2020 (2015) involved over 50 commitments for making England the best place in the world for dementia care, research and public dementia awareness in general. Feedback was subsequently collected, during 2018, concerning developments … Continue reading →

Attitudes Towards Dementia Report (BBC News / Alzheimer’s Research UK)

Posted on February 9, 2019 by Dementia and Elderly Care News

Summary Alzheimer’s Research UK (ARUK) have released a detailed report covering survey results about public attitudes towards dementia in the UK. Wave 1 of the Dementia Attitudes Monitor attempts to clarify the current state (using data from 2018) of the … Continue reading →

Posted in Alzheimer’s Research UK, BBC News, Charitable Bodies, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), In the News, Management of Condition, National, Quick Insights, Statistics, UK, Universal Interest | Tagged Alzheimer’s Research UK (ARUK), Asian and Minority Ethnic Communities, Attitudes Towards Dementia, Awareness and Understanding, Awareness of Physical and Mental Effects of Dementia, BBC Health News, Black Asian and Minority Ethnic (BAME), Black Asian and Minority Ethnic Communities (UK), Black Asian and Minority Ethnic Communities and Dementia, Changing Public Attitudes Towards Dementia, Dementia as a Cause of Death, Dementia Research, Dementia Risk Factors, Dr Laura Phipps: Alzheimer’s Research UK, Experiences, Experiences of Dementia, Hilary Evans: Chief Executive of Alzheimer’s Research UK, Iain Fossey: Communications Manager at Alzheimer’s Research UK, Ipsos Mori, Jane Stevens: Research Director at Ipsos MORI, Modifiable Risk Factors, Nick Philp: Research Director at Ipsos MORI, Opinion Polls, Protective Factors, Public Attitudes Towards Dementia, Public Attitudes Towards Dementia. Dementia Attitudes Monitor (ARUK), Public Opinion, Public Perception of Dementia, Reducing Stigma, Risk and Protective Factors, Risk and Protective Factors for Cognitive Decline and Dementia, Risk Factors, Risk Factors for Alzheimer's Diseease, Stigma, Stigma of Dementia, Trends in Attitudes Towards Dementia, UK Black Asian and Minority Ethnic Communities, UK’s Attitudes Towards Dementia and Research, Wave 1 of the Dementia Attitudes Monitor | Leave a comment

Tag Archives: Dementia Research

Blood Test Able to Predict Alzheimer’s Disease Decades Before Symptoms? (BBC News / Neurology)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites